Table 1.
Clinicopathological features of the cohort.
| Clinicopathological Features | Total (%) n = 292 |
|---|---|
| Gender | |
| Male | 166(57) |
| Female | 126 (43) |
| Age (Mean ± standard deviation) years | 70.8 ± 10.8 |
| UICC stage | |
| Stage I | 34 (11.8) |
| Stage II | 109 (37.8) |
| Stage III | 72 (24.9) |
| Stage IV | 74 (25.6) |
| Tumor location | |
| Left colon | 164 (56) |
| Right colon | 123 (42) |
| Multifocal | 5 (2) |
| Occlusion | |
| Yes | 34 (12) |
| No | 258 (88) |
| Tumor perforation | |
| Yes | 17 (6) |
| No | 275 (94) |
| Differentiation grade | |
| Grade 1–2 | 245 (84) |
| Grade 3 | 47 (16) |
| Annexin A10 | |
| Positive | 36 (12) |
| Negative | 255 (88) |
| KRAS status | |
| Wild type | 95 (67) |
| Mutant | 46 (33) |
| BRAF status | |
| Wild type | 246 (86) |
| Mutant | 40 (14) |
| Microsatellite status | |
| MSS | 250 (87) |
| MSI | 37 (13) |
| CIMP status | |
| No CIMP | 20 (35.7) |
| CIMP-Low | 30 (53.5) |
| CIMP-High | 6 (10.7) |